Boston Scientific stock is under fresh scrutiny as analysts adjust their price targets upward. The consensus figure is now $126.14, up from $124.53. This incremental rise reflects optimism fueled by ...
Boston Scientific posts $5.07 billion in Q3 revenue, beats earnings estimates, sees WATCHMAN growth at 35%, and raises 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback